These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
947 related articles for article (PubMed ID: 32467990)
21. Comprehensive analysis of lncRNA-associated ceRNA network reveals novel potential prognostic regulatory axes in glioblastoma multiforme. Bazrgar M; Mirmotalebisohi SA; Ahmadi M; Azimi P; Dargahi L; Zali H; Ahmadiani A J Cell Mol Med; 2024 Jun; 28(11):e18392. PubMed ID: 38864705 [TBL] [Abstract][Full Text] [Related]
22. Identification of Key Biomarkers and Potential Molecular Mechanisms in Oral Squamous Cell Carcinoma by Bioinformatics Analysis. Yang B; Dong K; Guo P; Guo P; Jie G; Zhang G; Li T J Comput Biol; 2020 Jan; 27(1):40-54. PubMed ID: 31424263 [TBL] [Abstract][Full Text] [Related]
23. Systematic identification of lncRNA-based prognostic biomarkers for glioblastoma. Li M; Long S; Hu J; Wang Z; Geng C; Ou S Aging (Albany NY); 2019 Nov; 11(21):9405-9423. PubMed ID: 31692451 [TBL] [Abstract][Full Text] [Related]
24. Identification of key genes involved in the recurrence of glioblastoma multiforme using weighted gene co-expression network analysis and differential expression analysis. Ren P; Wang J; Li L; Lin X; Wu G; Chen J; Zeng Z; Zhang H Bioengineered; 2021 Dec; 12(1):3188-3200. PubMed ID: 34238116 [TBL] [Abstract][Full Text] [Related]
25. Screening prognosis-related genes in glioblastoma by microarray analysis. Wang H; Zhang Y; Zhang C; Tong X Anticancer Drugs; 2020 Feb; 31(2):150-157. PubMed ID: 31567312 [TBL] [Abstract][Full Text] [Related]
26. Identification of Lin H; Yang Y; Hou C; Zheng J; Lv G; Mao R; Xu P; Chen S; Zhou Y; Wang P; Zhou D Genet Test Mol Biomarkers; 2021 May; 25(5):334-345. PubMed ID: 33970702 [No Abstract] [Full Text] [Related]
27. Identification of hub genes and regulatory factors of glioblastoma multiforme subgroups by RNA-seq data analysis. Li Y; Min W; Li M; Han G; Dai D; Zhang L; Chen X; Wang X; Zhang Y; Yue Z; Liu J Int J Mol Med; 2016 Oct; 38(4):1170-8. PubMed ID: 27572852 [TBL] [Abstract][Full Text] [Related]
28. Identification of key genes and associated pathways in KIT/PDGFRA wild‑type gastrointestinal stromal tumors through bioinformatics analysis. Wang WJ; Li HT; Yu JP; Li YM; Han XP; Chen P; Yu WW; Chen WK; Jiao ZY; Liu HB Mol Med Rep; 2018 Nov; 18(5):4499-4515. PubMed ID: 30221743 [TBL] [Abstract][Full Text] [Related]
29. Multi-omics analysis predicts fibronectin 1 as a prognostic biomarker in glioblastoma multiforme. Kabir F; Apu MNH Genomics; 2022 May; 114(3):110378. PubMed ID: 35513291 [TBL] [Abstract][Full Text] [Related]
30. mRNA markers for survival prediction in glioblastoma multiforme patients: a systematic review with bioinformatic analyses. Azimi P; Yazdanian T; Ahmadiani A BMC Cancer; 2024 May; 24(1):612. PubMed ID: 38773447 [TBL] [Abstract][Full Text] [Related]
31. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells. Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306 [TBL] [Abstract][Full Text] [Related]
32. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma. Li J; Liu X; Cui Z; Han G Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582 [TBL] [Abstract][Full Text] [Related]
33. Identification of candidate biomarkers for GBM based on WGCNA. Sun Q; Wang Z; Xiu H; He N; Liu M; Yin L Sci Rep; 2024 May; 14(1):10692. PubMed ID: 38724609 [TBL] [Abstract][Full Text] [Related]
34. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis. Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236 [TBL] [Abstract][Full Text] [Related]
35. Prospective Series of Nine Long Noncoding RNAs Associated with Survival of Patients with Glioblastoma. Lei B; Yu L; Jung TA; Deng Y; Xiang W; Liu Y; Qi S J Neurol Surg A Cent Eur Neurosurg; 2018 Nov; 79(6):471-478. PubMed ID: 29959764 [TBL] [Abstract][Full Text] [Related]
36. Construction of co-expression modules related to survival by WGCNA and identification of potential prognostic biomarkers in glioblastoma. Zhou J; Guo H; Liu L; Hao S; Guo Z; Zhang F; Gao Y; Wang Z; Zhang W J Cell Mol Med; 2021 Feb; 25(3):1633-1644. PubMed ID: 33449451 [TBL] [Abstract][Full Text] [Related]
37. Non-negative matrix factorization and differential expression analyses identify hub genes linked to progression and prognosis of glioblastoma multiforme. Akçay S; Güven E; Afzal M; Kazmi I Gene; 2022 May; 824():146395. PubMed ID: 35283227 [TBL] [Abstract][Full Text] [Related]
38. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis. Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311 [TBL] [Abstract][Full Text] [Related]
39. Weighted gene co‑expression network analysis for identifying hub genes in association with prognosis in Wilms tumor. Wang X; Song P; Huang C; Yuan N; Zhao X; Xu C Mol Med Rep; 2019 Mar; 19(3):2041-2050. PubMed ID: 30664180 [TBL] [Abstract][Full Text] [Related]
40. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis. Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]